Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial von Richter, Manuel J., Stollfuß, Barbara, Roitenberg, Alexander, Kleinjung, Frank, Graeff , Valentin, Berghaus, Sabine, Müller, Christian, Ghofrani, Hossein-Ardeschir

Volltext

Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE) von Zeymer, Uwe, Hohlfeld, Thomas, Dahl, Jürgen vom, Erbel, Raimund, Münzel, Thomas, Zahn, Ralf, Roitenberg, Alexander, Breitenstein, Stefanie, Ferenc Pap, Ákos, Trenk, Dietmar

Volltext

Abstract 14668: Prospective, Randomized Comparison of 500 mg and 250 mg Acetylsalicylic Acid I.v. and 300 mg p.o. in Patients With Acute Coronary Syndrome (ACUTE Trial) von Zeymer, Uwe, Vom Dahl, Juergen, Erbel, Raimund, Muenzel, Thomas, Trenk, Dietmar, Zahn, Ralf, Gebert, Irmgard, Roitenberg, Alexander, Hohlfeld, Thomas

Volltext

Evaluation of Clinical Outcomes and Simultaneous Digital Tracking of Daily Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension T... von Mueller, Christian, Stollfuss, Barbara, Roitenberg, Alexander, Harder, Jonas, Richter, Manuel J

Volltext